• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma industry news


Mylan shareholders approve proposed acquisition of Perrigo

28 August 2015

Mylan's proposed acquisition of Perrigo received the approval of two-thirds of the votes cast by Mylan shareholders at an extraordinary general meeting...


FDA approves LDL cholesterol drug Repatha

28 August 2015

Repatha, the second drug approved in a new class of drugs known as PCSK9 inhibitors, has been approved by the FDA for some patients who are unable to get their LDL cholesterol under control with current treatment options...


Novartis donates $40 million of treatments to treat leprosy

28 August 2015

Novartis has renewed its pledge with the World Health Organisation (WHO) to work to end leprosy by extending its donation of multidrug therapy medicines...


Celgene completes acquisition of Receptos for $7.2 billion

28 August 2015

Celgene has completed its acquisition of Receptos, significantly enhancing Celgene’s Inflammation & Immunology pipeline with the addition of Ozanimod...


Pharma leaders gather in Madrid at the CPhI Pre-Connect Congress

28 August 2015

CPhI Worldwide will once again be preceded by the Pre-Connect Congress when the global pharma community returns to Madrid October 13-15th...

Type 2 diabetes

Synjardy tablets receive FDA approval for adults with type 2 diabetes

27 August 2015

Synjardy approval was based on multiple clinical trials showing reductions in blood glucose versus placebo...

HRA Pharma launches new ellaOne website for pharmacists

HRA Pharma launches ellaOne® website for pharmacists

27 August 2015

HRA Pharma UK and Ireland has announced the launch of ellaonepharmacist.co.uk, a brand new website designed specifically for healthcare professionals which provides an educational resource for ellaOne® (30mg ulipristal acetate) accessible anytime.

Edwin Moses, Chief Executive Officer, Ablynx

Ablynx announces half-year results for 2015

27 August 2015

Ablynx has announced its business update and results for the six-month period ending 30 June 2015...


Combination of Roche medicines Cotellic and Zelboraf approved in Switzerland for the treatment of patients with advanced melanoma

27 August 2015

New treatment option for patients with difficult-to-treat form of skin cancer has shown improved treatment outcomes...


FDA approves Praluent for the treatment of high LDL cholesterol

26 August 2015

The US Food and Drug Administration (FDA) has approved Praluent (alirocumab) Injection - the first and only PCSK9 inhibitor approved in the US...


Alvogen to acquire four Pfizer products for the US market

26 August 2015

Alvogen is to acquire four pharmaceutical products from Pfizer, strengthening Alvogen’s commercial platform in the US market...


Largest Phase 3 trial of Ibrance in early breast cancer opens

26 August 2015

Alliance Foundation Trials, the Austrian Breast & Colorectal Cancer Study Group and Pfizer have launched the Palbociclib Collaborative Adjuvant Study...